EUVIMEDEUVIMED entdecken
ValidierungsstudieOpen Access · CC BY 4.0

A multiplex assay based on capillary electrophoresis to detect Mycobacterium tuberculosis complex: development and clinical validation

Yaocheng Wang, Zhen Li, Li Lai, Yiping Liu, Li Li, Yi Huang

Applied Microbiology and Biotechnology · 02.02.2026 · 110 (1)

DOI: 10.1007/s00253-025-13701-0 ↗

Kurz gefasst

Validierungsstudie in der Zeitschrift Applied Microbiology and Biotechnology, online erschienen am 02.02.2026. Verfasst von Yaocheng Wang und 5 weiteren Autor:innen. Beteiligte Einrichtung: Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, China. Hauptthemen laut MEDLINE: Mycobacterium tuberculosis, Multiplex Polymerase Chain Reaction, Molecular Diagnostic Techniques, Tuberculosis, Pulmonary. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 24 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Fujian Medical University, China, the Natural Science Foundation of Fujian Province, China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

This study presents a novel multiplex assay based on capillary electrophoresis (CE) for the simultaneous detection of three Mycobacterium tuberculosis complex (MTBC) genes: IS6110 , rpoB , and HSP65 . Unlike conventional molecular diagnostic methods that target only a single gene, which may lead to misdiagnosis or missed diagnosis, this CE-based multiplex approach provides comprehensive detection to reduce diagnostic errors. Specificity testing with 76 microorganisms representing common respiratory pathogens confirmed 100% analytical specificity with no cross-reactivity, while sensitivity analysis demonstrated detection limits ranging from 10 to 20 copies/mL for all three target genes. In a prospective clinical validation study of 1067 patients suspected of pulmonary tuberculosis, the multiplex assay showed 77.4% sensitivity (CI 74.9%–79.9%), 99.6% specificity (CI 99.2%–100%), 96.0% positive predictive value (CI 94.8%–97.2%), and 97.1% negative predictive value (CI 96.1%–98.1%). Notably, the study identified 6 MTBC strains (4.8% of TB patients) with IS6110 deletions through whole-genome sequencing, which would result in false-negative results for any commercial PCR kits targeting IS6110 . This integrated multiplex approach enhances diagnostic accuracy by simultaneously targeting multiple genes; then it offers the potential to reduce misdiagnosis and missed diagnosis of tuberculosis. In summary, the multiplex assay provides a more comprehensive alternative to current single-target molecular methods for MTBC detection. Key points • The multiplex assay provides one-run results for IS6110, rpoB, and HSP65. • The multiplex assay is a more comprehensive method to detect MTBC. • This approach can reduce misdiagnosis and missed diagnosis of TB.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Mycobacterium tuberculosisMultiplex Polymerase Chain ReactionMolecular Diagnostic TechniquesTuberculosis, PulmonaryHumansElectrophoresis, CapillarySensitivity and SpecificityBacterial ProteinsDNA-Directed RNA PolymerasesChaperonin 60Prospective StudiesDNA Transposable Elements

Stichwörter der Autor:innen

HSP65IS6110Mycobacterium tuberculosis complexrpoBCapillary electrophoresisMultiplex assay

Substanzen

Bacterial ProteinsDNA-Directed RNA PolymerasesChaperonin 60rpoB protein, Mycobacterium tuberculosisheat-shock protein 65, MycobacteriumDNA Transposable Elements

Autor:innen und Institutionen

  • Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, China.
  • Central Laboratory, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
  • Clinical Laboratory, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
  • Fujian Provincial Key Laboratory of Cardiovascular Disease, Fuzhou, China.
  • Tuberculosis Laboratory, International Medical Examination Center, Fujian Provincial Hospital, Fuzhou University Affiliated Provincial Hospital, Fuzhou, China.
  • Shengli Clinical Medical College of Fujian Medical University, Fujian Medical University, Fuzhou, China. lilifuzhou@126.com.

Förderung

  • Fujian Medical University, China
  • the Natural Science Foundation of Fujian Province, China

Zitieren

APA

Wang, Y., Li, Z., Lai, L., Liu, Y., Li, L., & Huang, Y. (2026). A multiplex assay based on capillary electrophoresis to detect Mycobacterium tuberculosis complex: development and clinical validation. Applied Microbiology and Biotechnology, 110(1). https://doi.org/10.1007/s00253-025-13701-0

Vancouver

Wang Y, Li Z, Lai L, Liu Y, Li L, Huang Y. A multiplex assay based on capillary electrophoresis to detect Mycobacterium tuberculosis complex: development and clinical validation. Applied Microbiology and Biotechnology. 2026;110(1). doi:10.1007/s00253-025-13701-0

BibTeX
@article{Wang2026,
  author = {Wang, Yaocheng and Li, Zhen and Lai, Li and Liu, Yiping and Li, Li and Huang, Yi},
  title = {A multiplex assay based on capillary electrophoresis to detect Mycobacterium tuberculosis complex: development and clinical validation},
  journal = {Applied Microbiology and Biotechnology},
  year = {2026},
  volume = {110},
  number = {1},
  doi = {10.1007/s00253-025-13701-0}
}
Kostenlos starten →